Moderna announces new vaccine candidates against Lyme disease and norovirus — Merck KGaA's multiple sclerosis drug hit with partial FDA hold — Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch -- See more on our front page news http://bit.ly/w28kSd #moderna #vaccines #mrna #lymedisease #norovirus #ms #multiplesclerosis #merckkgaa #fda #sanofi #rsv #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#moderna #vaccines #mrna #lymedisease #norovirus #ms #multiplesclerosis #merckkgaa #FdA #Sanofi #RSV #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA advisers question efficacy of Roche’s Polivy in first line LBCL— Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter — Merck KGaA makes its Foundry data tools available for free-- See more on our front page news http://bit.ly/w28kSd #fda #roche #lbcl #restructuring #novartis #ceos #executivepay #merckkgaa #opensource #datatools #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #roche #lbcl #restructuring #novartis #ceos #executivepay #merckkgaa #opensource #datatools #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA considers major shift in COVID vaccine strategy — Biogen/ Ionis ALS therapy set for March FDA AdCom meeting — Merck KGaA shrinks U.S. research team as layoffs continue to batter industry -- See more on our front page news http://bit.ly/w28kSd #fda #covid #covid19 #vaccines #biogen #als #fda #merckkgaa #layoffs #researchanddevelopment #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#FdA #covid #covid19 #vaccines #biogen #ALS #merckkgaa #layoffs #researchanddevelopment #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma